Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Throner SR"'
Autor:
Scott JS; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom., Moss TA; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom., Balazs A; Oncology R&D, AstraZeneca, R&D Boston, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States., Barlaam B; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom., Breed J; Discovery Sciences R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom., Carbajo RJ; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom., Chiarparin E; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom., Davey PRJ; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom., Delpuech O; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom., Fawell S; Oncology R&D, AstraZeneca, R&D Boston, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States., Fisher DI; Discovery Sciences R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom., Gagrica S; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom., Gangl ET; Oncology R&D, AstraZeneca, R&D Boston, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States., Grebe T; Oncology R&D, AstraZeneca, R&D Boston, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States., Greenwood RD; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom., Hande S; Oncology R&D, AstraZeneca, R&D Boston, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States., Hatoum-Mokdad H; Oncology R&D, AstraZeneca, R&D Boston, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States., Herlihy K; Discovery Sciences R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom., Hughes S; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom., Hunt TA; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom., Huynh H; Oncology R&D, AstraZeneca, R&D Boston, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States., Janbon SLM; Early Chemical Development, Pharmaceutical Sciences, R&D, Macclesfield, United Kingdom., Johnson T; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom., Kavanagh S; Oncology Safety, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge, United Kingdom., Klinowska T; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom., Lawson M; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom., Lister AS; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom., Marden S; Advanced Drug Delivery, Pharmaceutical Sciences, R&D, Boston, Massachusetts, United States., McGinnity DF; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom., Morrow CJ; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom., Nissink JWM; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom., O'Donovan DH; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom., Peng B; Oncology R&D, AstraZeneca, R&D Boston, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States., Polanski R; Discovery Sciences R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom., Stead DS; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom., Stokes S; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom., Thakur K; Oncology R&D, AstraZeneca, R&D Boston, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States., Throner SR; Oncology R&D, AstraZeneca, R&D Boston, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States., Tucker MJ; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom., Varnes J; Oncology R&D, AstraZeneca, R&D Boston, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States., Wang H; Oncology R&D, AstraZeneca, R&D Boston, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States., Wilson DM; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom., Wu D; Advanced Drug Delivery, Pharmaceutical Sciences, R&D, Boston, Massachusetts, United States., Wu Y; Oncology R&D, AstraZeneca, R&D Boston, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States., Yang B; Oncology R&D, AstraZeneca, R&D Boston, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States., Yang W; Advanced Drug Delivery, Pharmaceutical Sciences, R&D, Boston, Massachusetts, United States.
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2020 Dec 10; Vol. 63 (23), pp. 14530-14559. Date of Electronic Publication: 2020 Sep 29.
Autor:
Schou M; AstraZeneca Translational Science Centre at Karolinska Institutet, PET Centre of Excellence, Department of Clinical Neuroscience, S-17176 Stockholm, Sweden., Varnäs K; Department of Clinical Neuroscience, Psychiatry Section, Karolinska Institutet , S-17176 Stockholm, Sweden., Jureus A; AstraZeneca, Research & Development, Innovative Medicines, S-151 85 Södertälje, Sweden., Ahlgren C; AstraZeneca, Research & Development, Innovative Medicines, S-151 85 Södertälje, Sweden., Malmquist J; AstraZeneca, Research & Development, Innovative Medicines, S-151 85 Södertälje, Sweden., Häggkvist J; Department of Clinical Neuroscience, Psychiatry Section, Karolinska Institutet , S-17176 Stockholm, Sweden., Tari L; Department of Clinical Neuroscience, Psychiatry Section, Karolinska Institutet , S-17176 Stockholm, Sweden., Wesolowski SS; AstraZeneca, Research & Development, Innovative Medicines, Cambridge, Massachusetts 02451, United States., Throner SR; AstraZeneca, Research & Development, Innovative Medicines, Waltham, Massachusetts 02139, United States., Brown DG; AstraZeneca, Research & Development, Innovative Medicines, Waltham, Massachusetts 02139, United States., Nilsson M; AstraZeneca, Research & Development, Innovative Medicines, S-151 85 Södertälje, Sweden., Johnström P; AstraZeneca Translational Science Centre at Karolinska Institutet, PET Centre of Excellence, Department of Clinical Neuroscience, S-17176 Stockholm, Sweden., Finnema SJ; Department of Clinical Neuroscience, Psychiatry Section, Karolinska Institutet , S-17176 Stockholm, Sweden., Nakao R; Department of Clinical Neuroscience, Psychiatry Section, Karolinska Institutet , S-17176 Stockholm, Sweden., Amini N; Department of Clinical Neuroscience, Psychiatry Section, Karolinska Institutet , S-17176 Stockholm, Sweden., Takano A; Department of Clinical Neuroscience, Psychiatry Section, Karolinska Institutet , S-17176 Stockholm, Sweden., Farde L; AstraZeneca Translational Science Centre at Karolinska Institutet, PET Centre of Excellence, Department of Clinical Neuroscience, S-17176 Stockholm, Sweden.
Publikováno v:
ACS chemical neuroscience [ACS Chem Neurosci] 2016 Feb 17; Vol. 7 (2), pp. 177-84. Date of Electronic Publication: 2015 Nov 30.
Autor:
Brown DG; AstraZeneca CNS Discovery Research , 1800 Concord Pike, Wilmington, Delaware 19850, United States., Bernstein PR, Griffin A, Wesolowski S, Labrecque D, Tremblay MC, Sylvester M, Mauger R, Edwards PD, Throner SR, Folmer JJ, Cacciola J, Scott C, Lazor LA, Pourashraf M, Santhakumar V, Potts WM, Sydserff S, Giguère P, Lévesque C, Dasser M, Groblewski T
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2014 Feb 13; Vol. 57 (3), pp. 733-58. Date of Electronic Publication: 2014 Jan 27.
Autor:
Brown DG; CNS Discovery Research, AstraZeneca Pharmaceuticals , 1800 Concord Pike, Wilmington, Delaware 19850-5437, United States., Bernstein PR; CNS Discovery Research, AstraZeneca Pharmaceuticals , 1800 Concord Pike, Wilmington, Delaware 19850-5437, United States., Wu Y; CNS Discovery Research, AstraZeneca Pharmaceuticals , 1800 Concord Pike, Wilmington, Delaware 19850-5437, United States., Urbanek RA; CNS Discovery Research, AstraZeneca Pharmaceuticals , 1800 Concord Pike, Wilmington, Delaware 19850-5437, United States., Becker CW; CNS Discovery Research, AstraZeneca Pharmaceuticals , 1800 Concord Pike, Wilmington, Delaware 19850-5437, United States., Throner SR; CNS Discovery Research, AstraZeneca Pharmaceuticals , 1800 Concord Pike, Wilmington, Delaware 19850-5437, United States., Dembofsky BT; CNS Discovery Research, AstraZeneca Pharmaceuticals , 1800 Concord Pike, Wilmington, Delaware 19850-5437, United States., Steelman GB; CNS Discovery Research, AstraZeneca Pharmaceuticals , 1800 Concord Pike, Wilmington, Delaware 19850-5437, United States., Lazor LA; CNS Discovery Research, AstraZeneca Pharmaceuticals , 1800 Concord Pike, Wilmington, Delaware 19850-5437, United States., Scott CW; CNS Discovery Research, AstraZeneca Pharmaceuticals , 1800 Concord Pike, Wilmington, Delaware 19850-5437, United States., Wood MW; CNS Discovery Research, AstraZeneca Pharmaceuticals , 1800 Concord Pike, Wilmington, Delaware 19850-5437, United States., Wesolowski SS; CNS Discovery Research, AstraZeneca Pharmaceuticals , 1800 Concord Pike, Wilmington, Delaware 19850-5437, United States., Nugiel DA; CNS Discovery Research, AstraZeneca Pharmaceuticals , 1800 Concord Pike, Wilmington, Delaware 19850-5437, United States., Koch S; CNS Discovery Research, AstraZeneca Pharmaceuticals , 1800 Concord Pike, Wilmington, Delaware 19850-5437, United States., Yu J; CNS Discovery Research, AstraZeneca Pharmaceuticals , 1800 Concord Pike, Wilmington, Delaware 19850-5437, United States., Pivonka DE; CNS Discovery Research, AstraZeneca Pharmaceuticals , 1800 Concord Pike, Wilmington, Delaware 19850-5437, United States., Li S; CNS Discovery Research, AstraZeneca Pharmaceuticals , 1800 Concord Pike, Wilmington, Delaware 19850-5437, United States., Thompson C; CNS Discovery Research, AstraZeneca Pharmaceuticals , 1800 Concord Pike, Wilmington, Delaware 19850-5437, United States., Zacco A; CNS Discovery Research, AstraZeneca Pharmaceuticals , 1800 Concord Pike, Wilmington, Delaware 19850-5437, United States., Elmore CS; CNS Discovery Research, AstraZeneca Pharmaceuticals , 1800 Concord Pike, Wilmington, Delaware 19850-5437, United States., Schroeder P; CNS Discovery Research, AstraZeneca Pharmaceuticals , 1800 Concord Pike, Wilmington, Delaware 19850-5437, United States., Liu J; CNS Discovery Research, AstraZeneca Pharmaceuticals , 1800 Concord Pike, Wilmington, Delaware 19850-5437, United States., Hurley CA; Argenta , 8/9 Spire Green Centre, Flex Meadow, Harlow, Essex, CM19 5TR, United Kingdom., Ward S; Argenta , 8/9 Spire Green Centre, Flex Meadow, Harlow, Essex, CM19 5TR, United Kingdom., Hunt HJ; Argenta , 8/9 Spire Green Centre, Flex Meadow, Harlow, Essex, CM19 5TR, United Kingdom., Williams K; Argenta , 8/9 Spire Green Centre, Flex Meadow, Harlow, Essex, CM19 5TR, United Kingdom., McLaughlin J; CNS Discovery Research, AstraZeneca Pharmaceuticals , 1800 Concord Pike, Wilmington, Delaware 19850-5437, United States., Hoesch V; CNS Discovery Research, AstraZeneca Pharmaceuticals , 1800 Concord Pike, Wilmington, Delaware 19850-5437, United States., Sydserff S; CNS Discovery Research, AstraZeneca Pharmaceuticals , 1800 Concord Pike, Wilmington, Delaware 19850-5437, United States., Maier D; CNS Discovery Research, AstraZeneca Pharmaceuticals , 1800 Concord Pike, Wilmington, Delaware 19850-5437, United States., Aharony D; CNS Discovery Research, AstraZeneca Pharmaceuticals , 1800 Concord Pike, Wilmington, Delaware 19850-5437, United States.
Publikováno v:
ACS medicinal chemistry letters [ACS Med Chem Lett] 2012 Nov 12; Vol. 4 (1), pp. 46-51. Date of Electronic Publication: 2012 Nov 12 (Print Publication: 2013).
Autor:
Varnes JG; CNS Discovery Research, AstraZeneca Pharmaceuticals, Wilmington, DE 19850, USA. jeffrey.varnes@astrazeneca.com, Marcus AP, Mauger RC, Throner SR, Hoesch V, King MM, Wang X, Sygowski LA, Spear N, Gadient R, Brown DG, Campbell JB
Publikováno v:
Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2011 Mar 01; Vol. 21 (5), pp. 1402-6. Date of Electronic Publication: 2011 Jan 11.
Autor:
Brugel TA; CNS Discovery Research, AstraZeneca Pharmaceuticals, 1800 Concord Pike, Wilmington, DE 19850, USA., Smith RW, Balestra M, Becker C, Daniels T, Hoerter TN, Koether GM, Throner SR, Panko LM, Folmer JJ, Cacciola J, Hunter AM, Liu R, Edwards PD, Brown DG, Gordon J, Ledonne NC, Pietras M, Schroeder P, Sygowski LA, Hirata LT, Zacco A, Peters MF
Publikováno v:
Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2010 Oct 01; Vol. 20 (19), pp. 5847-52. Date of Electronic Publication: 2010 Jul 30.
Autor:
Brugel TA; CNS Discovery Research, AstraZeneca Pharmaceuticals, 1800 Concord Pike, Wilmington, DE 19850, USA. todd.brugel@astrazeneca.com, Smith RW, Balestra M, Becker C, Daniels T, Koether GM, Throner SR, Panko LM, Brown DG, Liu R, Gordon J, Peters MF
Publikováno v:
Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2010 Sep 15; Vol. 20 (18), pp. 5405-10. Date of Electronic Publication: 2010 Aug 03.